Real World Data on Safety and Efficacy of Pegylated Interferon (PEG-IFN) in Patients with Myeloproliferative Neoplasms (MPN)

被引：0
|
作者：
Garg, Mamta [1 ]
Agarwal, Siddharth [2 ]
Asagba, Graham [1 ]
机构：
[1] Univ Hosp Leicester, Leicester, Leics, England
[2] Univ Nottingham, Radiol, Nottigham, England
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-190467
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Efficacy and Safety of Pegylated Interferon in Myeloproliferative Neoplasms - A Regional Experience
    Ryan, Eileen
    Houston, Conal
    McDonald, Laura
    Byrne, Niamh O'Connor
    Whyte, Maureen
    Kumar, Sentil
    Elhassadi, Ezzat
    Hennessy, Brian
    Clifford, Ruth
    Mykytiv, Vitaliy
    O'Shea, Derville
    Keohane, Clodagh
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 118 - 118
  • [2] Outcomes of Patients with Myeloproliferative Neoplasms (MPN) after Interferon-Alpha (IFN) Therapy Discontinuation
    Soret, Juliette
    Cassinat, Bruno
    Chevret, Sylvie
    Dosquet, Christine
    Giraudier, Stephane
    Verger, Emmanuelle
    Maslah, Nabih
    Parquet, Nathalie
    Chomienne, Christine
    Kiladjian, Jean-Jacques
    BLOOD, 2016, 128 (22)
  • [3] Comparison of the Efficacy and Safety of Pegylated Interferon Alpha-2b and Common Interferon Alpha in Patients with Myeloproliferative Neoplasms
    Teng, Guangshuai
    Zhang, Yuhui
    Du, Chenxiao
    Wang, Yan
    Hu, Naibo
    Han, Yingdi
    Ma, Jinyu
    Gao, Shan
    Xiang, Guangpeng
    Shao, Zonghong
    Bai, Jie
    BLOOD, 2022, 140 : 3959 - 3960
  • [4] Pegylated Interferon Alpha-2a in Patients with Myeloproliferative Neoplasms (MPN): International Experience in 115 Cases
    Gowin, Krisstina
    Thapaliya, Prakash
    Samuelson, J.
    Harrison, C. N.
    Radia, Deepti
    Andreasson, Bjorn
    Mascarenhas, John
    Rambaldi, Alessandro
    Barbui, T.
    Rea, Catherine J.
    Camoriano, John
    Gentry, A.
    Kiladjian, Jean-Jacques
    O'Connell, Casey L.
    Mesa, Ruben A.
    BLOOD, 2011, 118 (21) : 1215 - 1215
  • [5] USE OF PEGYLATED INTERFERON ALFA-2A (PEG-IFN) IN THE SECOND LINE TREATMENT OF CHRONIC MYELOPROLIFERATIVE NEOPLASMS (NMP): EXPERIENCE OF THE CATALAN INSTITUTE OF ONCOLOGY (ICO)
    Quinones, T.
    Sagues, M.
    Osca, G.
    Estrada, N.
    Boque, C.
    Vallansot, R.
    Lopez-Brunso, M.
    Coll, R.
    Tuset, E.
    Gallardo, D.
    Xicoy, B.
    Zamora, L.
    HAEMATOLOGICA, 2019, 104 : 303 - 303
  • [6] Pegylated-Interferon 2α (Peg-IFN) suppresses β-catenin signaling in liver
    Thompson, Michael David
    Monga, Satdarshan
    FASEB JOURNAL, 2008, 22
  • [7] Efficacy of Prolonged Treatment With Pegylated Interferon (Peg-IFN) and Ribavirin in Thalassemic Patients With Hepatitis C Who Relapsed After Previous Peg-IFN-Based Therapy
    Sandoughdaran, Saleh
    Alavian, Seyed Moayed
    Sharafi, Heidar
    Behnava, Bita
    Salimi, Shima
    Mehrnoush, Leila
    Elizee, Pegah Karimi
    Keshvari, Maryam
    HEPATITIS MONTHLY, 2015, 15 (01)
  • [8] Use of Pegylated Interferon in Six Pediatric Patients with Myeloproliferative Neoplasms
    Kucine, Nicole
    Bergmann, Shayla
    Krichevsky, Spencer
    Jones, Devin
    Rytting, Michael E.
    Resar, Linda
    Mascarenhas, John
    Verstovsek, Srdan
    Hoffman, Ronald
    BLOOD, 2019, 134
  • [9] Pegylated interferon alfa-2b (PEG-IFN) plus ribavirin versus PEG-IFN for treatment of HIV/HCV co-infected patients (pts): An open, multicenter, randomized trial
    Cargnel, A
    Casella, A
    Angeli, E
    Gubertini, G
    Orlando, G
    Duca, P
    GASTROENTEROLOGY, 2002, 122 (04) : A630 - A630
  • [10] A RETROSPECTIVE ANALYSIS OF PEGYLATED-INTERFERON (PEG-IFN) TREATMENT OUTCOMES IN CHRONIC HEPATITIS B (CHB)
    Syed, Ahsan
    Lee, Sam
    Israelson, Heidi
    Pinto, Jacqui
    Coffin, Carla
    GASTROENTEROLOGY, 2018, 154 (06) : S728 - S728
12345